by Zoe Diana Draelos, MD; Steven Hall, PharmD; and Carey Munsick, MS Dr. Draelos is with Dermatology Consulting Services, PLLC, in High Point, North Carolina. Dr. Hall and Ms. Munsick are with Sandoz Inc., in Princeton, New Jersey. J Clin Aesthet Dermatol. 2020;13(8):E54–E58 FUNDING: This study was funded by PharmaDerm, a division of Fougera Pharmaceuticals. […]
J Clin Aesthet Dermatol. 2020;13(7):E53–E57 by Daniele Maggioni, PhD; Annamaria Cimicata, MS; Antonella Praticò, MS; Roberta Villa, MS; Ferdinando Bianchi, MD; Silvia Busoli Badiale, MS; Umberto Piana; and Claudio Angelinetta All authors are with Bio Basic Europe in Milan, Italy. FUNDING: No funding was provided for this study. DISCLOSURES: The authors have no conflicts of […]
J Clin Aesthet Dermatol. 2020;13(6):xx–xx by Sandrine Sebban, MD Dr. Sebban is in private practice in Paris, France. FUNDING: No funding was provided for this study. DISCLOSURES: The author owns shares in Soft Medical Aesthetics. ABSTRACT: Background. There is currently no standardized and reproducible injection technique to address facial aging at all anatomical levels. Objective. The Sebban […]
Background. Vitiligo is an acquired disorder characterized by depigmented macules or patches on the skin due to the loss of functional melanocytes. Segmental vitiligo (SV) is a subtype of vitiligo refractory to treatment.